The problem...
Numbness can be limiting, affecting your speech, your smile, and your ability to drink. You may even catch yourself drooling.
The solution...
OraVerse® is a breakthrough that reverses unwanted lingering numbness after routine dental procedures where local anesthetic containing a vasoconstrictor was used. In clinical trials, the patients were able to regain normal sensation twice as fast vs. the control group.
Median Time to Normal Lip Sensation
These studies showed that on average people who are given OraVerse not only return to normal sensation twice as fast, but they can smile, speak, and drink normally sooner, and drooling is minimized.
Median Time to Recovery of Normal Function
About OraVerse®
OraVerse is indicated for the reversal of soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor.
- OraVerse is not recommended for use in children less than 6 years of age or weighing less than 33 lbs.
- The most common adverse event with OraVerse greater than the control group was injection site pain (5% vs. 4%).
- OraVerse is administered by your dental professional in the same way the local anesthetic was given so that you can return to normal sensation and function faster.
If you'd like to have OraVerse as part of your next visit, just ask Dr. Sellinger if OraVerse is right for you.
For more information visit www.oraverse.com.
